| Literature DB >> 26730179 |
Fatemeh Moosavi1, Razieh Hosseini1, Luciano Saso2, Omidreza Firuzi3.
Abstract
Polyphenols are an important class of phytochemicals, and several lines of evidence have demonstrated their beneficial effects in the context of a number of pathologies including neurodegenerative disorders such as Alzheimer's and Parkinson's disease. In this report, we review the studies on the effects of polyphenols on neuronal survival, growth, proliferation and differentiation, and the signaling pathways involved in these neurotrophic actions. Several polyphenols including flavonoids such as baicalein, daidzein, luteolin, and nobiletin as well as nonflavonoid polyphenols such as auraptene, carnosic acid, curcuminoids, and hydroxycinnamic acid derivatives including caffeic acid phentyl ester enhance neuronal survival and promote neurite outgrowth in vitro, a hallmark of neuronal differentiation. Assessment of underlying mechanisms, especially in PC12 neuronal-like cells, reveals that direct agonistic effect on tropomyosin receptor kinase (Trk) receptors, the main receptors of neurotrophic factors including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) explains the action of few polyphenols such as 7,8-dihydroxyflavone. However, several other polyphenolic compounds activate extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/Akt pathways. Increased expression of neurotrophic factors in vitro and in vivo is the mechanism of neurotrophic action of flavonoids such as scutellarin, daidzein, genistein, and fisetin, while compounds like apigenin and ferulic acid increase cyclic adenosine monophosphate response element-binding protein (CREB) phosphorylation. Finally, the antioxidant activity of polyphenols reflected in the activation of Nrf2 pathway and the consequent upregulation of detoxification enzymes such as heme oxygenase-1 as well as the contribution of these effects to the neurotrophic activity have also been discussed. In conclusion, a better understanding of the neurotrophic effects of polyphenols and the concomitant modulations of signaling pathways is useful for designing more effective agents for management of neurodegenerative diseases.Entities:
Keywords: Trk; flavonoids; hydroxycinnamic acids; neurodegeneration; neuroprotective
Mesh:
Substances:
Year: 2015 PMID: 26730179 PMCID: PMC4694682 DOI: 10.2147/DDDT.S96936
Source DB: PubMed Journal: Drug Des Devel Ther ISSN: 1177-8881 Impact factor: 4.162
Figure 1Main classes of polyphenols and their chemical structures.
Figure 2Chemical structures of flavonoids with neurotrophic activity.
Figure 3Chemical structures of polyphenols with neurotrophic activity that do not belong to the group of flavonoids.
Induction of neurite outgrowth by polyphenols and involvement of neurotrophic signaling pathways
| Compound | Source | Cell model | Involved signaling pathways
| References | ||
|---|---|---|---|---|---|---|
| MEK/ERK1/2 | PI3K/Akt | PLCγ –PKC | ||||
| Artepillin C | Chemical | PC12 cells | Y | – | – | |
| CAPE | Chemical | PC12 cells | – | – | – | |
| Daidzein | Chemical | DRG cultures | Y | – | Y | |
| 7,8-DHF | Chemical | Cultured embryonic mouse motoneurons and SGNs | Y | Y | – | |
| EGCG | Chemical | PC12 cells | – | – | Y | |
| Fisetin | Chemical | PC12 cells | Y | – | – | |
| Isoquercitrin | Chemical | NG108-15 neuroblastoma/glioma cells | – | – | – | |
| Luteolin | Chemical | PC12 cells | Y | – | Y | |
| Methyl 3,4-dihydroxybenzoate | Chemical | Cortical neurons of neonatal rats | – | Y | – | |
| Resveratrol | Chemical | PC12 cells, neuro2a cells, and primary rat midbrain neuron-glia and neuron-astroglia cultures | Y | – | – | |
| 7,8,3′-Trihydroxyflavone | Chemical | SGN | Y | – | – | |
| Auraptene | Citrus plants | PC12 cells | Y | – | – | |
| Baicalein | C17.2 NSCs | Y | – | – | ||
| Carnosic acid | PC12 cells | Y | Y | – | ||
| Curcuminoids | PC12 cells | Y | – | Y | ||
| 3,7-Dihydroxy-2,4,6-trimethoxy-phenanthrene | Mouse neuro2a (N2a) cells | – | – | – | ||
| Nobiletin | PC12D cells | Y | – | – | ||
| Oroxylin | Cultured rat primary neuron | Y | Y | – | ||
| Protocatechuic acid | Cultured NSC/NPCs | – | – | – | ||
| Quercetin | P19-derived neurons | – | Y | – | ||
Note:
Not determined.
Abbreviations: N, activation of the pathway is not involved; Y, activation of the pathway is involved; CAPE, caffeic acid phenethyl ester; 7,8-DHF, 7,8-dihydroxyflavone; DRG, dorsal root ganglia; EGCG, epigallocatechin–gallate; ERK, extracellular signal-regulated kinase; MEK, mitogen-activated protein kinase kinase; NSC/NPCs, neural stem/progenitor cells; PI3K, phosphoinositide 3-kinase; PKC, protein kinase C; PLCγ, phospholipase Cγ; SGNs, spiral ganglion neurons.
Increased expression of neurotrophic factors by polyphenols in cell and animal models
| Compound | Cell model | Animal model | Involved signaling pathways | Neurotrophic factors that are modulated | Function | References |
|---|---|---|---|---|---|---|
| Alpinetin | Primary rat astrocytes | – | Estrogen signaling | BDNF, NGF, GDNF | – | |
| Astilbin | – | Mice | p-ERK/p-Akt | BDNF | Antidepressant-like effects | |
| Baicalein | – | Mouse model of amnesia | p-ERK/p-CREB | BDNF | Antidepressant-like effects | |
| Butein | – | Mice | p-ERK/p-CREB | BDNF | Cognition enhancement | |
| CAPE | – | Mice | Nrf2/ARE | BDNF | Protection of nigral dopaminergic neurons | |
| Calycosin | Primary rat astrocytes | – | Estrogen signaling | BDNF, NGF, GDNF | – | |
| Chrysin | – | Mice | – | BDNF | Cognition enhancement | |
| Curcumin | – | Rats | Akt/GSK-3β | BDNF | Suppression of β-amyloid-induced cognitive impairments | |
| Daidzein | H19-7 neural cell line | – | – | BDNF | – | |
| Ferulic acid | NSC/NPCs | Mice | p-CREB | BDNF | Antidepressant-like effects | |
| Fisetin | – | Mouse model of amnesia | p-ERK/p-CREB | BDNF | Cognition enhancement | |
| Genistein | Primary rat astrocytes | – | Estrogen signaling | BDNF, NGF, GDNF | – | |
| Genistein | H19-7 neural cell line | – | – | BDNF | – | |
| HMF | – | Mouse model of ischemia | p-ERK/p-CREB | BDNF | – | |
| Isorhamnetine | Primary rat astrocytes | – | Estrogen signaling | BDNF, NGF, GDNF | – | |
| Luteolin | Primary rat astrocytes | – | Estrogen signaling | BDNF, NGF, GDNF | – | |
| Oroxylin A | Primary cortical neurons | – | PI3K-Akt | BDNF | – | |
| Puerarin | – | Rats | Nrf2/ARE | BDNF | Attenuation of neuronal degeneration | |
| Quercetin | – | Rats | PGC-1α | BDNF | Amelioration of hypobaric hypoxia-induced memory deficit | |
| Resveratrol | Dopaminergic neurons | Rats | p-ERK/p-CREB | BDNF, GDNF | Antidepressant-like effects | |
| Rosmarinic acid | – | Rats | p-ERK | BDNF | Antidepressant-like effects | |
| Scutellarin | Primary rat astrocytes | – | p-CREB/p-Akt | BDNF, NGF, GDNF | – | |
| – | Rats | – | BDNF, NGF | Antidepressant-like effects |
Note:
Not determined in this study.
Abbreviations: CAPE, caffeic acid phenethyl ester; HMF, 3,5,6,7,8,3′,4′-heptamethoxyflavone; BDNF, brain-derived neurotrophic factor; NGF, nerve growth factor; GDNF, glial cell line-derived neurotrophic factor; NSC/NPCs, neural stem/progenitor cells; ERK, extracellular signal-regulated kinase.
Figure 4Main signaling pathways that mediate the neurotrophic effects of various polyphenols.
Notes: By activation of the Trk receptors, neurotrophic signaling starts mainly through the Ras/MAPK, PI3K/Akt, and PL-Cγ pathways. Trk binding by polyphenols results in the autophosphorylation and activation of these receptors. Receptor phosphorylation forms adaptor-binding sites that couple the receptor to MAPKs, PI3K, and phospholipase Cγ (PLCγ1) pathways, which ultimately result in the phosphorylation of CREB protein. Phosphorylated CREB bound to the CBP leads to the increased transcription of target genes by binding to CRE. These genes are involved in survival, differentiation, growth, synaptic plasticity, and long-term memory. Polyphenols-ER binding also activates neurotrophic effects via PKC pathways. 1: Epicatechin, 2: 7,8,3’-trihydroxyflavone, 3: diosmetin 4: 7, 8-dihydroxyflavone, 5: daidzein, 6: resveratrol, 7: hesperetin, 8: curcuminoids, 9: caffeic acid phenethyl ester, 10: ferulic acid, 11: baicalein, 12: apigenin, 13: honokiol, 14: nobiletin, 15: pinocembrin, 16: astilbin, 17: artepillin C, 18: 3,5,6,7,8,3′,4′-heptamethoxyflavone, 19: 4′-O-β-D-glucopyranosyl-30,4-dimethoxychalcone, 20: fustin, 21: puerarin, 22: scutellarin, 23: oroxylin A, 24: methyl 3,4-dihydroxybenzoate, 25: carnosic acid, 26: rosmarinic acid, 27: luteolin, 28: auraptene, 29: epigallocatechin-3-gallate, 30: icaritin, 31: liquiritin, 32: fisetin, 33: rutin.
Abbreviations: CaMK, Ca2+-calmodulin kinase; CREB, cyclic adenosine monophosphate response element-binding protein; CBP, CREB-binding protein; DAG, diacylglycerol; ER, estrogen receptor; ERK, extracellular signal-regulated kinase; IP3, inositol trisphosphate; MAPK, mitogen-activated protein kinase; MEK, mitogen-activated protein kinase kinase; PI3K, phosphatidylinsoitol-3-kinase; PKC, protein kinase C; PLCγ, phospholipase Cγ; Trk, tropomyosin receptor kinase.
Neuronal survival and differentiation induced by polyphenols and contribution of different neurotrophic pathways to these effects
| Compound | Cell model | Activation of pathway
| References | ||
|---|---|---|---|---|---|
| MEK/ERK1/2 | PI3K/Akt | PLCγ –PKC | |||
| Artepillin C | PC12m3 cells | Y | – | – | |
| Auraptene | PC12 cells | Y | – | – | |
| Baicalein | C17.2 NSCs | Y | – | – | |
| Caffeic acid phenethyl ester | Rat organotypic midbrain slice cultures | Y | – | – | |
| Carnosic acid | PC12 cells | Y | Y | – | |
| Carnosic acid | PC12 cells | Y | – | – | |
| Curcuminoids | PC12 cells | Y | – | Y | |
| Daidzein | Primary rat DRG neuronal cultures | Y | – | Y | |
| 7,8-Dihydroxyflavone | Mouse hippocampal cultures and mouse embryonic motoneuron cultures | N | Y | – | |
| 7,8-Dihydroxyflavone | Retinal ganglion cell cultures | Y | Y | – | |
| 4′-O-β-D-Glucopyranosyl-3′, 4-dimethoxychalcone | PC12 Cells | Y | N | – | |
| HMF | Mouse neuronal cells | Y | – | – | |
| Hesperetin | PC12 cells | Y | Y | Y | |
| Luteolin | PC12 cells | Y | – | Y | |
| Luteolin | PC12 cells | Y | – | – | |
| Methyl 3,4-dihydroxybenzoate | Rat cortical neuronal cultures | – | Y | – | |
| Nobiletin | PC12D cells | Y | – | – | |
| Oroxylin A | Cortical neuronal cultures | – | Y | – | |
| Puerarin | PC12 cells | Y | Y | – | |
| Resveratrol | Astrocytes cultures | Y | – | – | |
| Rosmarinic acid | PC12 cells | Y | – | – | |
Note:
Not determined.
Abbreviations: N, activation of the pathway is not involved; Y, activation of the pathway is involved; DRG, dorsal root ganglion; ERK, extracellular signal-regulated kinase; HMF, 3,5,6,7,8,3′,4′-heptamethoxyflavone; MEK, mitogen-activated protein kinase kinase; NSCs, neural stem cells; PKC, protein kinase C; PLCγ, phospholipase Cγ.
Improvement of memory and modulation of other brain functions in animal models by polyphenols and involvement of neurotrophic signaling pathways
| Compound | Animal model | Effect on brain function | Involved signaling pathways
| References | ||
|---|---|---|---|---|---|---|
| MEK/ERK1/2 | PI3K/Akt | PLCγ–PKC | ||||
| Apigenin | Mice | Improvement of learning and memory in APP/PS1 mice | Y | – | – | |
| Baicalein | Mice | Memory enhancement | Y | – | – | |
| Baicalein | Mice | Prevention of spatial learning and memory deficits following irradiation | Y | – | – | |
| Curcumin | Rats | Improvement of amyloid-β-induced cognitive impairment | – | Y | – | |
| Ferulic acid | Mice | Antidepressant-like effect | Y | Y | Y | |
| Fisetin | Mice | Memory enhancement | Y | – | – | |
| HMF | Mice | Enhancement of neurogenesis after brain ischemia | Y | – | – | |
| Nobiletin | Mice | Improvement of memory in olfactory-bulbectomized mice | Y | – | – | |
| Pinocembrin | Mice | Improvement of cognitive deficits in APP/PS1 mice | Y | – | – | |
| Resveratrol | Mice | Improvement of hippocampal atrophy in chronic fatigue syndrome mice | Y | – | – | |
| Rutin | Rats | Memory enhancement | Y | – | – | |
Note:
Not determined.
Abbreviations: Y, activation of the pathway is involved; ERK, extracellular signal-regulated kinase; HMF, 3,5,6,7,8,3′,4′-heptamethoxyflavone; MEK, mitogen-activated protein kinase kinase; PKC, protein kinase C; PLCγ, phospholipase Cγ.
Inhibition of neurotoxin-induced damage by polyphenols and neurotrophic signaling pathways that possibly contribute to this effect
| Compound | Animal or cell model | Action of neurotoxin | Involved signaling pathway
| References | ||
|---|---|---|---|---|---|---|
| MEK/ERK1/2 | PI3K/Akt | PLCγ–PKC | ||||
| Baicalein | C17.2 NSCs | Irradiation-induced cell death and neurogenesis deficit | Y | – | – | |
| Baicalein | SH-SY5Y cells | 6-OHDA-induced damage in SH-SY5Y cells | Y | – | – | |
| Caffeic acid | SH-SY5Y cells | 6-OHDA-induced damage in SH-SY5Y cells | N | Y | – | |
| CAPE | PC12 cells | Dopaminergic neurotoxin MPP+ induced injury in PC12 cells | Y | – | – | |
| Carnosic acid | SH-SY5Y cells | Amyloid-β-induced apoptosis in SH-SY5Y cells | Y | Y | – | |
| Curcumin | PC12 cells | Cisplatin-induced neurite toxicity | Y | – | Y | |
| Curcumin | Rats | Amyloid-β-induced neuronal injury | – | Y | – | |
| 7,8-DHF | Mice | Kainic acid-induced neurotoxicity | Y | Y | – | |
| 7,8-DHF | HT-22 cells | Glutamate-induced toxicity in HT-22 cells | Y | Y | – | |
| EGCG | Mice | Striatal and substantia nigra dopaminergic neuron loss induced by MPTP | – | – | Y | |
| Icaritin | Cortical neuronal cells | Amyloid-β-induced neurotoxicity | Y | – | – | |
| Icariin | Primary cultured rat hippocampal neurons | Corticosterone-induced apoptosis | Y | – | – | |
| Liquiritin | Primary cultured hippocampal neurons | Amyloid-β-induced neurotoxicity | Y | – | – | |
| Puerarin | PC12 cells | Dopaminergic neuronal damage in PC12 cells and behavioral impairments in MPTP-induced neurotoxicity in mice | Y | Y | – | |
| Resveratrol | Schwann cells | Ethanol-induced injury | Y | – | – | |
| Rutin | Rat | Protective effects against neurotoxicity of Aβ | Y | – | – | |
Note:
Not determined.
Abbreviations: N, activation of the pathway is not involved; Y, activation of the pathway is involved; Aβ, Amyloid-β; CAPE, caffeic acid phenethyl ester; 7,8-DHF, 7,8-dihydroxyflavone; EGCG, epigallocatechin–gallate; ERK, extracellular signal-regulated kinase; MEK, mitogen-activated protein kinase kinase; MPP+, (1-methyl-4-phenylpyridinium); MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NSC, neural stem cell; 6-OHDA, 6-hydroxydopamine; PI3K, Phosphoinositide 3-kinase; PKC, protein kinase C; PLCγ, phospholipase Cγ.
Figure 5Polyphenols activate Keap1/Nrf2/ARE pathway and increase the expression of detoxification/antioxidant enzymes.
Notes: In the cytoplasm, Keap1 protein is always bound to Nrf2 transcription regulator and prevents its signaling. Polyphenols directly or indirectly cause dissociation of Nrf2–Keap1 complex and subsequent nuclear translocation of Nrf2. In the nucleus, Nrf2 binds to the ARE in the regulatory region of the target genes and stimulates transcription of detoxification/antioxidant enzymes HO-1, GCL, GPx, GST, SOD, CAT, PRX, and Trx.
Abbreviations: ARE, antioxidant response element; CAT, catalase; EGCG, epigallocatechin–gallate; ERK, extracellular signal-regulated kinase; GCL, γ-glutamylcysteine synthetase; GPx, glutathione peroxidase; GST, glutathione S-transferase; HO-1, heme oxygenase-1; Nrf2, Nuclear factor E2-related factor 2; PKC, protein kinase C; PRX, peroxiredoxin; SOD, superoxide dismutase; Trx, thioredoxin.